Lv1
60 积分 2025-03-14 加入
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
7小时前
待确认
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2个月前
已完结
TSLP AND IL-13 Dual Blockade By Lunsekimig Provides Broader Benefits On Type-2 Inflammation
2个月前
已关闭
717 - Clinical efficacy, safety, and pharmacokinetic profile of bosakitug (BSI-045B), an anti-thymic stromal lymphopoietin (TSLP) mAb in a phase 2 study of moderate and severe atopic dermatitis subjects
3个月前
已完结
皖公网安备34019202002308
